About Clario
Clario is a Healthcare company based in Philadelphia (United States) founded in 1972, and was acquired by Thermo Fisher Scientific in November 2025. CRO focused on providing clinical trial supply services for biopharma sector. The company has 11 employees. Clario has completed 19 acquisitions, including APDM, ArtiQ and Biomedical Systems. Its website clario.com draws about 115 thousand monthly visits. Its Indian entity Qinecsa Solutions India Private Limited reported revenue of ₹166 Cr. Clario offers products and services including eCOA Clinical Trials, Cardiac Solutions, Medical Imaging, and Respiratory Solutions. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include Lightship, SFJ Pharmaceuticals and N-Power Medicine; 2 of its 3 listed competitors have raised funding.
Company details
Clario was established in 1972 in Philadelphia, United States, as a contract research organization. Clinical trial supply services are delivered to the biopharma sector, supporting trial logistics and management. Operations encompass supply chain coordination, inventory tracking, and regulatory compliance across global sites. The focus remains on efficient resource distribution for pharmaceutical and biotechnology studies, with headquarters in the United States.
- Headquarters Philadelphia, United States
- Employees 11
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website clario.com
- Social LinkedIn X
- Acquired by Thermo Fisher Scientific (Nov 2025)
- Legal Name Qinecsa Solutions India Private Limited
- Date of Incorporation 08 Dec, 2008
- Indian entity revenue₹166 Cr
FY 2025 · -13% YoY
- Indian entity net profit₹26.84 Cr
FY 2025 · 16% margin
- Indian entity EBITDA₹39.48 Cr
FY 2025 · 24% margin
- Latest Funding Round$699.22K (USD), Grant
Jun 2012
- InvestorsThermo Fisher Scientific
& 1 more
- Employee Count11
- Investments & AcquisitionsAPDM
& 18 more
- Acquired by
Associated legal entities of Clario
Clario operates through Qinecsa Solutions India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Qinecsa Solutions India Private Limited CIN U72200KA2008FTC048542 | Active | 08 Dec 2008 | Mysore, Karnataka | ₹166 Cr | 1,317 | 4 | View details |
Products & Services of Clario
Clario offers a comprehensive portfolio of products and services, including eCOA Clinical Trials, Cardiac Solutions, Medical Imaging, and Respiratory Solutions.
Platform for electronic outcome assessments in clinical trials.
Services for arrhythmia analysis and ECG monitoring in trials.
Tools for image analysis and repository management in research.
Devices for spirometry and lung sound analysis in studies.
Funding Insights of Clario
- Total Rounds 1
- Last Round Grant — $699,219
- First Round $699,219
(Jun 2012)
- Investors Count 1
All 1 funding rounds of Clario with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2012 | $699,219 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Clario
Clario has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Thermo Fisher Scientific and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Electron microscopy services and microanalysis instruments are provided. | 1956 | thermofisher.com | Waltham, United States | |
| hhs.gov |
Investor details for Clario
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Qinecsa Solutions India Private Limited (Clario)
Qinecsa Solutions India Private Limited is the primary company behind Clario. The board of Qinecsa Solutions India Private Limited currently have 4 directors; the longest-serving is Mahesh Sreenivasa Prabhu, appointed in 2022. 21 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Mahesh Sreenivasa Prabhu DIN 06671578 | Director | 12 Mar 2022 | 4 yrs 8 mo | Qinecsa Solutions India Private Limited |
| Humaira Aftab Qureshi DIN 09534655 | Director | 12 Mar 2022 | 4 yrs 8 mo | Qinecsa Solutions India Private Limited |
| Nagaraj Muniswamy DIN 10173125 | Director | 24 May 2023 | 3 yrs 5 mo | Qinecsa Solutions India Private Limited |
| Adam Sherlock DIN 09428222 | Additional Director | 04 Nov 2025 | 1 yr | Qinecsa Solutions India Private Limited |
People of Clario
500 people are tracked at Clario (193 in leadership, 307 in team); the tracked headcount is 11.
| Name | Role | Group |
|---|---|---|
Mike Reintjes | Senior Director, Ecoa Sales | Leadership |
Sanjay Chablani | Sr. Director Software Quality Engineering | Leadership |
Chris Tague | Vice President, Global Respiratory Solutions | Leadership |
Wesley Degraen | Director Clinical Data Programming | Leadership |
Anne Gruosso | Director Project Management - Portfolio Management, Medical Imaging | Leadership |
Christoph Speh | Director, R&d Software Engineering | Leadership |
John Orr | Senior Director Strategic Sourcing | Leadership |
Nadia R. Ayat | Director, Medical And Scientific Affairs | Leadership |
Britt Wallace | Director, Ecoa Solutions | Leadership |
Matthew Borer | Director, Portfolio Sales - CRO Partnerships | Leadership |
Brian Rafter | Director, Cardiac Project Management | Leadership |
Joyce Suhy | Executive Vice President, Medical Imaging | Leadership |
Marcela Vieira | Medical Director | Leadership |
Susan Custren | Director, Clinical Project Management | Leadership |
Nina Gilbert | Director, Sr. Technical Product Manager | Leadership |
Jeff Phillips | Vp, Product Management | Leadership |
Karla S. | Director, R&d Program Management | Leadership |
Aimee Schraml | Vice President, Strategy & Corporate Development | Leadership |
Marin Bosnic | Talent Development Business Partner | Leadership |
Jeanne Jackson | Director, Clinical Project Management, Cardiovascular Services | Leadership |
480 more people are available in the full profile.
Complete people profiles for Clario
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Clario
Figures of Qinecsa Solutions India Private Limited, the primary company behind Clario, for FY 2025. Revenue was ₹166 Cr (-13% year on year). Net profit was ₹26.84 Cr (16% margin). EBITDA was ₹39.48 Cr (24% margin). Revenue has grown at a compounded annual rate of -23% over three years and -2% over five years.
- ₹166 CrRevenue · FY 2025 · -13% YoY
- ₹26.84 CrNet profit · 16% margin
- ₹39.48 CrEBITDA · 24% margin
- ₹1 LakhPaid-up capital
- 1,317Employees (provident fund records)
- -23%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Qinecsa Solutions India Private Limited are on its company page.
Detailed financial statements for Clario
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clario
Clario has strategically engaged in corporate development activities, having acquired 19 companies. Notable acquisitions include APDM, ArtiQ and Biomedical Systems.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Clinical trials on neurological diseases are conducted by NeuroRx. | neurorx.com | Montreal, Canada | 2003 | Mar 2025 | •••• | |
AI-powered software to optimize clinical trials and enhance diagnostic processes | artiq.eu | Leuven, Belgium | 2019 | Apr 2024 | •••• | |
Adverse events and product quality are captured for life sciences. | mymedsandme.com | London, United Kingdom | 2012 | Apr 2022 | •••• | |
Medical imaging workflows for clinical trials are provided. | saliency.com | Menlo Park, United States | 2020 | Jan 2021 | •••• | |
Wearable sensors are developed to monitor body movements continuously. | apdm.com | Portland, United States | 2007 | Jun 2020 | •••• | |
Cardiac safety testing and respiratory laboratory services are provided. | icardiac.com | Rochester, United States | 2006 | Dec 2017 | •••• | |
Biomedical data collection software | mddx.com | Newark, United States | 2008 | Nov 2017 | •••• | |
Provider of specialized clinical trial services like cardiac safety testing, imaging and eCOA related services | biomedsys.com | St. Louis, United States | 1975 | Sep 2017 | •••• | |
Digital clinical images are managed via a specialized platform. | image-iq.com | Cleveland, United States | 2011 | May 2017 | •••• | |
Mobile phone applications for clinical trial management and patient engagement | excointouch.com | Nottingham, United Kingdom | 2004 | Dec 2016 | •••• |
Complete acquisition details for Clario
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Clario
13 dated milestones of Clario across 53 years, from founding to its latest funding, stage changes and deals.
- Founded Clario is founded.
- Funding First funding round of $699K.
- Acquisition Acquires Exco InTouch.
- Acquisition Acquires ImageIQ.
- Acquisition Acquires Biomedical Systems.
- Acquisition Acquires MDDX.
- Acquisition Acquires iCardiac Technologies.
- Acquisition Acquires APDM.
- Acquisition Acquires Saliency.
- Acquisition Acquires My Meds & Me.
- Acquisition Acquires ArtiQ.
- Acquisition Acquires NeuroRx.
- Exit Acquired by Thermo Fisher Scientific.
Competitors of Clario
Clario has 3 listed competitors in our database, 2 of them funded. They include Lightship, SFJ Pharmaceuticals and N-Power Medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lightship.com | 1995 | El Segundo, United States | $205.55M | 74 | Direct-to-patient clinical trial solutions are provided by Lightship. | |
| sfj-pharma.com | 2008 | Pleasanton, United States | $69.5M | 12 | Specialty pharmaceutical company based on partnering model | |
| npowermedicine.com | 2021 | Redwood, United States | Clinical trial services are provided to support medical research initiatives. |
Detailed competitors of Clario
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Clario
The website of Clario (clario.com) receives about 114.9K visits a month.
- Monthly visits114.9K
▲ 8.4% vs previous month
Websites whose visitors overlap most with Clario. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
fptech.co.uk | fptech.co.uk | 100% | – | ||
mid.co.uk | mid.co.uk | 100% | – | ||
e-zoneuk.com | e-zoneuk.com | 100% | – | ||
twistgraphics.co.uk | twistgraphics.co.uk | 100% | – | ||
ixdstudio.com | ixdstudio.com | 100% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 19 similar websites and full traffic analytics for Clario
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 19 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Clario (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clario
Complete news archive for Clario
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clario
Clario was founded in 1972 and raised its 1st funding round 40 years after it was founded.
Clario is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Clario has 11 employees.
The primary company behind Clario, Qinecsa Solutions India Private Limited, reported revenue of ₹166 Cr for FY 2025, down 13% year on year.
Clario was established in 1972 in Philadelphia, United States, as a contract research organization. Clinical trial supply services are delivered to the biopharma sector, supporting trial logistics and management. Operations encompass supply chain coordination, inventory tracking, and regulatory compliance across global sites. The focus remains on efficient resource distribution for pharmaceutical and biotechnology studies, with headquarters in the United States.
Clario's top competitors include Lightship, SFJ Pharmaceuticals and N-Power Medicine.
Clario offers eCOA Clinical Trials, Cardiac Solutions, Medical Imaging, and Respiratory Solutions.
Clario has made 19 acquisitions, including APDM, ArtiQ, and Biomedical Systems.
Clario has 2 investors. Key investors include Thermo Fisher Scientific, and HHS.
Clario operates through Qinecsa Solutions India Private Limited.
Yes. Clario was acquired by Thermo Fisher Scientific in November 2025.
The legal entities of Clario currently have 4 directors, including Mahesh Sreenivasa Prabhu, Nagaraj Muniswamy, Humaira Aftab Qureshi and others.